Effects of the extract of Anemopaegma mirandum (Catuaba) on Rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells

Brain Research

Volumn 1198, Issue , 2008, Pages 188-196

  De Andrade, Deyse Valverde G ^a   Madureira de Oliveria, Diêgo ^a   Barreto, George ^a   Bertolino, Laura Aon ^b   Saraceno, Ezequiel ^b   Capani, Francisco ^b   Giraldez, Lisandro Diego ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Catuaba; Cytoprotective; Parkinson disease; Rotenone; SH SY5Y cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANEMOPAEGMA MIRANDUM EXTRACT; PLANT EXTRACT; ROTENONE;

ANEMOPAEGMA MIRANDUM; APOPTOSIS; ARTICLE; BRAZIL; CELL MEMBRANE; CELL NUCLEUS; CELL PROTECTION; CELL ULTRASTRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; HUMAN; HUMAN CELL; MEDICINAL PLANT; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; STAINING; SYMPTOMATOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

ANEMOPAEGMA MIRANDUM;

EID: 43049095135     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.01.006     Document Type: Article

References (53)

1. Barbosa N.R. Fischmann L. Talib L.L. Gattaz W.F. Inhibition of platelet phospholipase A2 activity by Catuaba extract suggests anti-inflammatory properties Phytother. Res. 18 2004 942 944
2. Beal M.F. Metabolic disorders and neurotoxicology Curr. Opin. Neurol. 8 1995 467 468
3. Beal M.F. Oxidatively modified proteins in aging and disease Free Radic. Biol. Med. 32 2002 797 803
4. Betarbet R. Sherer T.B. MacKenzie G. Garcia-Osuna M. Panov A.V. Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
5. Betarbet R. Sherer T.B. Greenamyre J.T. Animal models of Parkinson's disease Bioessays. 24 2002 308 318
6. Bradshaw J. Saling M. Hopwood M. Anderson V. Brodtmann A. Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct J. Neurol. Neurosurg. Psychiatry. 75 2004 382 387
7. Brown T.P. Rumsby P.C. Capleton A.C. Rushton L. Levy L.S. Pesticides and Parkinson's disease—is there a link? Environ Health Perspect. 114 2006 156 164
8. Carlini E.A. Plants and the central nervous system Pharmacol. Biochem. Behav. 75 2003 501 512
9. Charam I. Há ações afrodisíacas nas plantas medicinais do Brasil? Folha Méd. 94 1987 303 309
10. Coimbra, R., 1994. Manual de fitoterapia. vol. 84, ed. Cejup, Belém, PA.
11. Connolly G.P. Cell imaging and morphology. Application to studies of inherited purine metabolic disorders Pharmacol. Ther. 90 2001 267 281
12. Cumming J.L. Zhong K. Treatments for behavioural disorders in neurodegenerative diseases: drug development strategies Nat. Rev. Drug Discov. 5 2006 64 74
13. Dale E.B. Rammohan V.R. Patrick M. Cell death in the nervous system Nature 443 2006 796 802
14. Davies K.J. Oxidative stress: the paradox of aerobic life Biochem. Soc. Symp. 61 1995 1 31
15. Dexter D.T. Holley A.E. Flitter W.D. Increase levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study Mov. Disord. 9 1994 92 97
16. Eberhardt O. Schulz J.B. Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease Toxicol. Lett. 4 2003 135 151
17. Fagan A.M. Mintun M.A. Mach R.H. Lee S.Y. Dence C.S. Shah A.R. LaRossa G.N. Spinner M.L. Klunk W.E. Mathis C.A. DeKosky S.T. Morris J.C. Holtzman D.M. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans Ann. Neurol. 59 2006 512 519
18. Graf E. Lude W. Alkaloids from Erythroxylum vacciniifolium Martius, 1: Isolation of catuabine A, B and C Arch. Pharm. (Weinheim) 310 1977 1005 1010
19. Graf E. Lude W. Alkaloids from Erythroxylum vacciniifolium Martius, 2: The structures of catuabine A, B and C Arch. Pharm. (Weinheim) 311 1978 139 152
20. Greenamyre J.T. Hastings T.G. Biomedicine: Parkinson's-divergent causes, convergent mechanisms Science 304 2004 1120 1122
21. Greenamyre J.T. Sherer T.B. Betarbet R. Panov A.V. Complex I and Parkinson's disease IUBMB Life 52 2001 135 141
22. Hansen M.B. Nielsen S.E. Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immunol. Methods 12 1989 203 210
23. Hara H. Ohta M. Adachi T. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway J. Neurosci. Res. 84 2006 860 866
24. Hori H. Ohmori O. Shinkai T. Kojima H. Okano C. Suzuki T. Nakamura J. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to Tardive dyskinesia Neuropsychopharmacology 23 2000 170 177
25. Ishimaru M.J. Ikonomidou C. Tenkova T.I. Der T.C. Dikranian K. Sesma M.A. Olney J.W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain J. Comp. Neurol. 408 1999 461 476
26. Jenner P. Olanow C.W. Understanding cell death in Parkinson's disease Ann. Neurol. 44 1998 72 84
27. Karbowski M. Norris K.L. Cleland M.M. Jeong S.Y. Youle R.J. Role of Bax and Bak in mitochondrial morphogenesis Nature 443 2006 658 662
28. Kerr J.F. Wyllie A.H. Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br. J. Cancer 26 1972 239 257
29. La Thangue N.B. A mismatched role for Bcl-2 Nat. Cell Biol. 7 2005 101 102
30. Li N. Ragheb K. Lawler G. Sturgis J. Rajwa B. Melendez J.A. Robinson J.P. Mitochondrial complex I inhibitor Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production J. Biol. Chem. 278 2002 8516 8525
31. Liu C.L. Siesjo B.K. Hu B.R. Pathogenesis of hippocampal neuronal death after hypoxia–ischemia changes during brain development Neuroscience 127 2004 113 123
32. Mattson M.P. Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
33. Mattson M.P. Mitochondrial regulation of neuronal plasticity Neurochem. Res. 32 2007 707 715
34. Molina-Jimenez M.F. Sanchez-Reus M.I. Benedi J. Effect of fraxetin and myricetin on Rotenone-induced cytotoxicity in SH-SY5Y cells: comparison with N -acetylcysteine Eur. J. Pharmacol. 472 2003 81 87
35. Newhouse K. Shih-Ling H. Chang S.H. Cai B. Wang Y. Xia Z. Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells Toxicol. Sci. 79 2004 137 146
36. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63
37. Oliveira C.H. Moraes M.E. Moraes M.O. Bezerra F.A. Abib E. De Nucci G. Clinical toxicology study of an herbal medicinal extract of Paullinia cupana , Trichilia catigua , Ptychopetalum olacoides and Zingiber officinale (Catuama) in healthy volunteers Phytother. Res. 19 2005 54 57
38. Seaton T.A. Cooper J.M. Schapira A.H. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors Brain Res. 777 1997 110 118
39. Sheldon R.A. Hall J.J. Noble L.J. Ferriero D.M. Delayed cell death in neonatal mouse hippocampus from hypoxia-ischemia is neither apoptotic nor necrotic Neurosci. Lett. 304 2001 165 168
40. Sherer T.B. Betarbet R. Greenamyre J.T. Environment, mitochondria, and Parkinson's disease Neuroscientist 8 2002 192 197
41. Sherer T.B. Betarbet R. Stout A.K. Lund S. Baptista M. Panov A.V. Cookson R. Greenamyre J.T. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J. Neurosci. 22 2002 7006 7015
42. Shirwaikar A. Shirwaikar A. Rajendran K. Punitha I.S. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine Biol. Pharm. Bull. 29 2006 1906 1910
43. Sipos I. Tretter L. Adam-Vizi V. Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals J. Neurochem. 84 2003 112 118
44. Sipos I. Tretter L. Adam-Vizi V. The production of reactive oxygen species in intact isolated nerve terminals is independent of the mitochondrial membrane potential Neurochem. Res. 28 2003 1575 1581
45. Tabanca N. Pawar R.S. Ferreira D. Marais J.P. Khan S.I. Joshi V. Wedge D.E. Khan I.A. Flavan-3-ol-phenylpropanoid conjugates from Anemopaegma arvense and their antioxidant activities Planta Med. 73 2007 1107 1111
46. Tan S. Sagara Y. Liu Y. Maher P. Schubert D. The regulation of reactive oxygen species production during programmed cell death J. Cell Biol. 141 1998 1423 1432
47. Tarozzi A. Morroni F. Hrelia S. Angeloni C. Marchesi A. Cantelli-Forti G. Hrelia P. Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells Neurosci. Lett. 424 2007 36 40
48. Uchino T. Kawahara N. Sekita S. Satake M. Saito Y. Tokunaga H. Ando M. Potent protecting effects of Catuaba ( Anemopaegma mirandum ) extracts against hydroperoxide-induced cytotoxicity Toxicol. In Vitro 18 2004 255 263
49. Watanabe M. Hitomi M. van der Wee K. Rothenberg F. Fisher S.A. Zucker R. Svoboda K.K. Goldsmith E.C. Heiskanen K.M. Nieminen A.L. The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs Microsc. Microanal. 8 2002 375 391
50. Wyllie A.H. Apoptosis: an overview Br. Med. Bull. 53 1997 451 465
51. Younes-Mhenni S. Frih-Ayed M. Kerkeni A. Bost M. Chazot G. Peripheral blood markers of oxidative stress in Parkinson's disease Eur. Neurol. 58 2007 78 83
52. Zanolari B. Guilet D. Marston A. Queiroz E.F. Paulo M.Q. Hostettmann K. Methylpyrrole tropane alkaloids from the bark of Erythroxylum vacciniifolium J. Nat. Prod. 68 2005 1153 1158
53. Zanolari B. Wolfender J.L. Guilet D. Marston A. Queiroz E.F. Paulo M.Q. Hostettmann K. On-line identification of tropane alkaloids from Erythroxylum vacciniifolium by liquid chromatography-UV detection-multiple mass spectrometry and liquid chromatography-nuclear magnetic resonance spectrometry J. Chromatogr. 1020 2003 75 89